Whole-body MRI and PET-CT can both examine large areas of the body, but they do not answer every cancer question in the same way. The best choice depends on the cancer type, the stage of care, and what the doctor needs to find out.
What whole-body MRI shows
MRI uses a magnetic field and radio waves to produce detailed images without ionising radiation. Whole-body MRI can be useful for some bone marrow disorders, cancers that commonly spread to bone, and surveillance in certain people with a high inherited cancer risk.
It takes longer than many CT examinations and requires the patient to remain still. Availability and image quality can vary, and it is not the preferred test for every organ or tumour.
What PET-CT shows
PET-CT combines a radioactive tracer study with CT images. The PET part shows patterns of tracer uptake, while the CT part shows where those patterns are in the body.
The commonly used FDG tracer may collect in metabolically active cancer, but it can also collect in infection, inflammation, healing tissue, and normal organs. Some cancers do not take up FDG strongly. PET-CT is useful for selected cancers when staging disease, assessing response to treatment, or looking for recurrence.
Why one is not simply better
| Feature | Whole-body MRI | PET-CT | | :--- | :--- | :--- | | Main information | Detailed tissue structure and some functional information | Tracer activity linked to CT anatomy | | Ionising radiation | No | Yes | | Common cancer uses | Selected bone marrow, bone, and inherited-risk pathways | Selected staging, treatment-response, and recurrence questions | | Important limitation | Not equally useful for every tumour or body area | Uptake is not specific to cancer, and some cancers show little uptake |
Doctors may choose one, use both at different times, or choose a focused CT, MRI, ultrasound, or bone scan instead.
Whole-body scanning is not routine screening for everyone
A whole-body scan can find harmless changes that lead to anxiety, extra tests, cost, and sometimes procedures. For people without symptoms or a recognised high-risk pathway, there is no single whole-body scan proven to screen reliably for every cancer.
Anyone considering a scan as a general health check should first ask what cancers it can reasonably detect, what it may miss, and what will happen if an uncertain finding appears.
The bottom line
Whole-body MRI and PET-CT are useful in specific clinical settings. The name of the scan matters less than whether it is the right tool for the cancer and the question being asked.